216974-75-3[Bevacizumab (Anti-Human VEGF, Humanized Antibody)]- Acmec Biochemical

2,4-dichloro-6-methyl-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine

5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1,17-bis(1,1-dimethylethyl) ester

tert-butyl 8-oxo-2,7-diazaspiro[4.4]nonane-2-carboxylate

Obtucarbamate B

2-Fluoro-4-nitro-1-(trifluoromethyl)benzene

3-Hydroxy-2-(1-imidazolyl)propanoic Acid

PROPYLENE GLYCOL BUTYL ETHER

Tulobuterol

2,4-Dichloronicotinic acid

Fluoroacetone

CAS No：430-51-3

Dimethyl pyridine-3,5-dicarboxylate

1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethanone

tert-Butyl (3S)-3-(hydrazinecarbonyl)piperidine-1-carboxylate

3-Pyridinemethanamine, 6-chloro-2-methoxy-

3-(2-Hydroxyphenyl)propanamide

H-Lys-OMe.2HCl

7-Amino-4,4-dimethyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one

Potassium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate

Quipazine (maleate)

Methyl 5-hydroxy-1-naphthoate

X78775	CAS:216974-75-3	Bevacizumab, ≥95%, Acmec		Price inventory Collection

Bevacizumab (Anti-Human VEGF, Humanized Antibody)